| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 0.85 | 0.14 (+19.72%) | 0.63 - 2.45 | 16.7 thousand (Above Avg) |
Market data as of 3:56PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 0.77 |
|---|---|
| Previous Close | 0.71 |
| Day's Range | 0.77 - 0.85 |
| Market Cap | 10.3M |
| Avg Volume (10 Day) | 9.5K |
| Price/Earnings (Trailing 12 Mo.) | 2.8x |
| Earnings Per Share (Trailing 12 Mo.) | 1.1 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Neutral |
| Stock is undervalued? | Fail |
| Have investors caught on? | Neutral |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Fail |
Nephros Announces Completion of Rights Offering
PR Newswire - Thursday 05/23/2013 4:30 PM ET
Nephros Reports First Quarter 2013 Financial Results
PR Newswire - Wednesday 05/08/2013 4:15 PM ET
| NEPH | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -- | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | 35.71% | |
| Price/Sales | 2.54 |
| Company | Last | Change |
|---|---|---|
| NeuroMetrix Inc | 1.91 | -1.55% |
| Pro-Dex Inc | 1.90 | 0.00% |
| IsoRay Inc | 0.48 | -3.58% |
| Lakeland Industries Inc | 3.69 | -3.15% |
| Oculus Innovative Sciences Inc | 4.34 | +4.33% |
Data is delayed by at least 15 min.